WW Q1 2026 Earnings Deep EPS Miss Amidst Strategic Transformation Fulcrum Therapeutics Q1 2026 Earnings Narrowed Loss Exceeds Analyst Expectations AGIG Q3 2012 Earnings Significant EPS Miss Sends Stock Lower FNLC Q1 2026 Earnings Modest Performance Amid Narrowing Margins INTT Q1 2026 Earnings Strong EPS Beat Driven by Operational Execution Encore Capital Group Q1 2026 Earnings Strong EPS Beat of 2646 Amid Stock Decline